Novel production method of innovative antiangiogenic and antitumor small peptides in Escherichia coli

BACKGROUND: Developing innovative drugs with potent efficacy, specificity, and high safety remains an ongoing task in antitumor therapy development. In the last few years, peptide drugs have become attractive agents in cancer therapy. HM-3, mainly with antiangiogenic effect, and AP25, with an additi...

Descripción completa

Detalles Bibliográficos
Autores principales: Setrerrahmane, Sarra, Yu, Jian, Hao, Jingchao, Zheng, Heng, Xu, Hanmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685134/
https://www.ncbi.nlm.nih.gov/pubmed/29184391
http://dx.doi.org/10.2147/DDDT.S136957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685134/
https://www.ncbi.nlm.nih.gov/pubmed/29184391
http://dx.doi.org/10.2147/DDDT.S136957

Ejemplares similares